133 related articles for article (PubMed ID: 19512992)
1. Comments on "Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial" by Dr Ko and colleagues.
Pae CU
J Clin Psychopharmacol; 2009 Apr; 29(2):194-5; author reply 196-7. PubMed ID: 19512992
[No Abstract] [Full Text] [Related]
2. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial.
Ko YH; Lew YM; Jung SW; Joe SH; Lee CH; Jung HG; Lee MS
J Clin Psychopharmacol; 2008 Aug; 28(4):375-83. PubMed ID: 18626263
[TBL] [Abstract][Full Text] [Related]
3. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.
Seidman SN; Orr G; Raviv G; Levi R; Roose SP; Kravitz E; Amiaz R; Weiser M
J Clin Psychopharmacol; 2009 Jun; 29(3):216-21. PubMed ID: 19440073
[TBL] [Abstract][Full Text] [Related]
4. Heart failure therapy: testosterone replacement and its implications.
Rauchhaus M; Doehner W; Anker SD
Eur Heart J; 2006 Jan; 27(1):10-2. PubMed ID: 16291772
[No Abstract] [Full Text] [Related]
5. No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.
Lotstra F; Verbanck P; Mendlewicz J; Vanderhaeghen JJ
Biol Psychiatry; 1984 Jun; 19(6):877-82. PubMed ID: 6378259
[No Abstract] [Full Text] [Related]
6. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
[No Abstract] [Full Text] [Related]
7. Hydergine for schizophrenia.
Cohen MR; Pary R; Burns R
J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
[No Abstract] [Full Text] [Related]
8. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
9. Goldilocks and menopause.
Vigersky RA
Arch Intern Med; 2005 Jul; 165(14):1571-2. PubMed ID: 16043673
[No Abstract] [Full Text] [Related]
10. Regarding "N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial".
Hashimoto K
Biol Psychiatry; 2008 Nov; 64(9):e1. PubMed ID: 18718574
[No Abstract] [Full Text] [Related]
11. [Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. A randomized, double-blind, placebo-controlled study].
Romanò M
Ital Heart J Suppl; 2001 Feb; 2(2):203-4. PubMed ID: 11255887
[No Abstract] [Full Text] [Related]
12. Outpatient use of a double-blind medication trial: a clinical example.
Diamond RJ
J Clin Psychiatry; 1983 Aug; 44(8):304-5. PubMed ID: 6874651
[TBL] [Abstract][Full Text] [Related]
13. Androgens and the breast.
von Schoultz B
Maturitas; 2007 May; 57(1):47-9. PubMed ID: 17386984
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone augmentation as an adjunctive treatment in schizophrenia.
Howes OD; Hundal H
J Clin Psychopharmacol; 2009 Apr; 29(2):195-6; author reply 196-7. PubMed ID: 19512993
[No Abstract] [Full Text] [Related]
15. Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials.
Zhou T; Hu ZY; Zhang HP; Zhao K; Zhang Y; Li Y; Wei JJ; Yuan HF
Curr Med Sci; 2018 Feb; 38(1):191-198. PubMed ID: 30074170
[TBL] [Abstract][Full Text] [Related]
16. Treatment of schizophrenia with a vasopressin analogue.
Iager AC; Kirch DG; Bigelow LB; Karson CN
Am J Psychiatry; 1986 Mar; 143(3):375-7. PubMed ID: 3513631
[TBL] [Abstract][Full Text] [Related]
17. A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophrenia.
Grebb JA; Shelton RC; Taylor EH; Bigelow LB
Biol Psychiatry; 1986 Jun; 21(7):691-4. PubMed ID: 3518822
[No Abstract] [Full Text] [Related]
18. A randomized, double-blind, controlled trial of testosterone gel treatment versus vehicle control on the facial hair of young men with beta-thalassemia major.
Saeedi M; Kosaryan M; Fekri K; Adabi M; Mahdavi MR
J Dermatolog Treat; 2007; 18(5):271-4. PubMed ID: 17852629
[TBL] [Abstract][Full Text] [Related]
19. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic effect of rescue remedy for psychiatric patients: a double-blind, placebo-controlled, randomized trial.
Muhlack S; Lemmer W; Klotz P; Müller T; Lehmann E; Klieser E
J Clin Psychopharmacol; 2006 Oct; 26(5):541-2. PubMed ID: 16974206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
